본문으로 건너뛰기
← 뒤로

Machine learning identifies TIME subtypes linking EGFR mutations and immune states in lung adenocarcinoma.

NPJ digital medicine 2025 Vol.8(1) p. 796

Gong Z, Du M, Li Y, Ye B, Huang Y, Gong H, Wang W, Chen L, Ding Z, Zhang P

📝 환자 설명용 한 줄

Epidermal growth factor receptor (EGFR) mutation is a key oncogenic driver in lung adenocarcinoma (LUAD), but its impact on the tumor immune microenvironment (TIME) remains unclear.

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Gong Z, Du M, et al. (2025). Machine learning identifies TIME subtypes linking EGFR mutations and immune states in lung adenocarcinoma.. NPJ digital medicine, 8(1), 796. https://doi.org/10.1038/s41746-025-02172-2
MLA Gong Z, et al.. "Machine learning identifies TIME subtypes linking EGFR mutations and immune states in lung adenocarcinoma.." NPJ digital medicine, vol. 8, no. 1, 2025, pp. 796.
PMID 41299024

Abstract

Epidermal growth factor receptor (EGFR) mutation is a key oncogenic driver in lung adenocarcinoma (LUAD), but its impact on the tumor immune microenvironment (TIME) remains unclear. By integrating single-cell transcriptomes from 153 LUAD samples using machine learning, we generated an atlas of over one million cells that delineates immune heterogeneity. EGFR-mutant tumors exhibited enrichment of TIGITregulatory T cells, neutrophils, and macrophages, whereas wild-type tumors contained abundant ZNF683CD8tissue-resident memory T cells, diverse memory B cells, and FGFBP2CD16 natural killer cells, reflecting an immune-active TIME. Non-negative matrix factorization defined five TIME subtypes, with EGFR-mutant patients clustering into immunosuppressive profiles linked to poor prognosis. Flow cytometry and mouse models confirmed the cytotoxic and PD-1 blockade-enhancing functions of FGFBP2NK cells. These findings reveal distinct TIME landscapes in EGFR-mutant LUAD and illustrate the potential of machine learning-based immunogenomic analysis to inform precision immunotherapy.

같은 제1저자의 인용 많은 논문 (5)